From November 1, 2023 to January 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 120,300 shares, representing 0.89% for $0.71 million under the buyback announced on April 5, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | -1.08% | +1.55% | -18.15% |
1st Jan change | Capi. | |
---|---|---|
-18.15% | 62.53M | |
+45.53% | 57.87B | |
+40.77% | 40.25B | |
-7.02% | 39.94B | |
-5.16% | 28.54B | |
+11.01% | 26.4B | |
-20.02% | 19.33B | |
+31.11% | 12.4B | |
-1.02% | 12.23B | |
+23.13% | 12.2B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.